Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ) Share Price

Price 1.40p on 30-01-2026 at 19:35:07
Change -0.05p -3.45%
Buy 1.50p
Sell 1.30p
Last Trade: Buy 1,000.00 at 1.465p
Day's Volume: 598,485
Last Close: 1.40p
Open: 1.45p
ISIN: GB00BNG2VN02
Day's Range 1.40p - 1.45p
52wk Range: 1.25p - 2.45p
Market Capitalisation: £5.55m
VWAP: 1.345551p
Shares in Issue: 396.39m

Cizzle Biotech (CIZ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,000 1.465p Ordinary
16:06:59 - 30-Jan-26
Unknown* 496,739 1.316p Ordinary
14:35:46 - 30-Jan-26
Buy* 100,683 1.49p Ordinary
10:58:08 - 30-Jan-26
Buy* 63 1.60p Ordinary
08:36:05 - 30-Jan-26
Buy* 6 1.60p Ordinary
16:04:36 - 29-Jan-26
Sell* 101,585 1.32p Ordinary
08:00:55 - 29-Jan-26
Buy* 100,000 1.50p Ordinary
14:08:19 - 28-Jan-26
Buy* 19,108 1.50p Ordinary
13:12:53 - 28-Jan-26
Sell* 9,072 1.32p Ordinary
13:08:33 - 28-Jan-26
Buy* 25,000 1.50p Ordinary
13:05:00 - 28-Jan-26
See more Cizzle Biotech trades

Cizzle Biotech (CIZ) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jan 2026 (Fri) 1.45 1.45 1.40 1.40 598,485
29th Jan 2026 (Thu) 1.45 1.45 1.45 1.45 101,591
28th Jan 2026 (Wed) 1.45 1.45 1.45 1.45 257,116
27th Jan 2026 (Tue) 1.45 1.45 1.45 1.45 933
26th Jan 2026 (Mon) 1.45 1.45 1.45 1.45 554,384
23rd Jan 2026 (Fri) 1.45 1.45 1.45 1.45 516
22nd Jan 2026 (Thu) 1.45 1.45 1.45 1.45 507,958
21st Jan 2026 (Wed) 1.45 1.45 1.45 1.45 41,692
20th Jan 2026 (Tue) 1.45 1.45 1.45 1.45 62,456
19th Jan 2026 (Mon) 1.45 1.45 1.45 1.45 50,139
16th Jan 2026 (Fri) 1.55 1.55 1.45 1.45 1,567,337
15th Jan 2026 (Thu) 1.55 1.55 1.55 1.55 201,296
14th Jan 2026 (Wed) 1.40 1.55 1.40 1.55 605,718
13th Jan 2026 (Tue) 1.40 1.40 1.40 1.40 195,896
12th Jan 2026 (Mon) 1.55 1.55 1.35 1.40 2,042,907
9th Jan 2026 (Fri) 1.55 1.55 1.55 1.55 264,554
8th Jan 2026 (Thu) 1.55 1.55 1.55 1.55 2,656,073
7th Jan 2026 (Wed) 1.55 1.55 1.55 1.55 167,212
6th Jan 2026 (Tue) 1.55 1.55 1.55 1.55 43,017
5th Jan 2026 (Mon) 1.55 1.55 1.55 1.55 314,683
2nd Jan 2026 (Fri) 1.55 1.55 1.55 1.55 45,038
See more Cizzle Biotech price history

Cizzle Biotech (CIZ) Regulatory News

Date Source Headline
5th Nov 2025 7:01 am RNS £250,000 Convertible Loan Note Issue
5th Nov 2025 7:00 am RNS LOI with leading UK Clinical Diagnostic Group
27th Oct 2025 11:32 am RNS Change of Registered Office
30th Sep 2025 7:00 am RNS Interim Results
29th Sep 2025 7:00 am RNS Update on Clinical Laboratory Partnerships in USA
18th Aug 2025 7:00 am RNS Commercial Progress in USA
30th Jun 2025 1:45 pm RNS Result of AGM
6th Jun 2025 11:00 am RNS Notice of AGM
28th May 2025 7:00 am RNS Holding(s) in Company
20th May 2025 7:00 am RNS £150,000 Convertible Loan Note Issue
See more Cizzle Biotech regulatory news

Cizzle Biotech (CIZ) Share News

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract

18th Aug 2025 22:11

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds

20th May 2025 21:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Cizzle Biotech news
FTSE 100 Latest
Value10,223.54
Change51.78

Login to your account

Forgot Password?

Not Registered